We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Nextstellis

ACNU Feasibility

View full report
GoodNextstellis is an oral progestin tablet with moderate side effects and interaction risks, requiring daily adherence and periodic monitoring, especially for certain populations. It has low misuse potential and straightforward dosing but demands careful use to maintain efficacy and safety.

ACNU Feasibility Scorecard

Chart with 11 data points.
Nextstellis
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.